Previous Page  4 / 10 Next Page
Information
Show Menu
Previous Page 4 / 10 Next Page
Page Background

Page 29

Notes:

conferenceseries

.com

Volume 7, Issue 6 (Suppl)

J Clin Exp Pathol, an open access journal

ISSN:2161-0681

Digital Pathology 2017

November 15-16, 2017

November 15-16, 2017 San Antonio, USA

2

nd

International Conference on

Digital Pathology & Image Analysis

Synchronous ipsilateral clear cell renal cell carcinoma and chromophobe renal cell carcinoma: A

case report and review of literature

Anila Chughtai, Khadija Shafqat, Mohammad Fayyaz Anwer

and

Akhtar Sohail Chughtai

Chughtai lab, Pakistan

C

ollision tumor is a phenomenon in which two histologically different tumors exist as distinct lesions within same organ.

Renal tumors represent 3% of adult malignancies and 2% of childhood malignancies but their synchronous occurrence

is very rare. We present a case of synchronous tumors of kidney comprising clear cell renal cell carcinoma (CCRCC) and

chromophobe renal cell carcinoma (CRCC). Grossly, two separate tumor nodules were identified with unremarkable

intervening area. Microscopic examination from both tumor nodules revealed two different epithelial malignancies. Sections

from larger nodules revealed nests of cells with distinct cell borders, hyperchromatic nuclei, perinuclear halos and eosinophilic

granular cytoplasmwhile sections from smaller nodule revealed sheets and nests of cell with hyperchromatic nuclei, prominent

nucleoli and clear to eosinophilic cytoplasm. Sections from intervening area showed renal parenchyma without any tumor

infiltration. Larger tumor was positive for CK7 and CD117 immunohistochemical (IHC) stains while negative for CD10 IHC

stain confirming the diagnosis of CRCC. However smaller tumor was positive for CD-10 IHC stain and negative for CK7 IHC

stain confirming the diagnosis of CCRCC. Prognosis in such cases is determined by the more aggressive of the two tumors as

in our case CCRCC is more aggressive with a 5 year survival rate of 50-60% as compared to CRCC with a 5 year survival rate

of 80-90%.

Biography

Anila Chughtai has completed her Bachelor of Medicine & Bachelor of Surgery degrees (MBBS) from Services Institute of Medical Sciences, Lahore. Currently, she

is working as a second year Post-graduate trainee at Chughtai lab Lahore.

anee.usman.666@gmail.com

Anila Chughtai et al., J Clin Exp Pathol 2017, 7:6 (Suppl)

DOI: 10.4172/2161-0681-C1-043